Skip to main content
. 2018 Jul 28;18:186. doi: 10.1186/s12886-018-0850-y

Fig. 2.

Fig. 2

Kaplan-Meier survival analysis for each group: (a) Overall survival (OS) for patients with VA ≥20/400 versus VA < 20/400 (b) OS for patients with tumor size ≤20 mm versus tumor size > 20 mm. (c) OS for patients with no distant metastasis, regional nodal metastasis versus distant metastasis. (d) OS for patients with or without recurrent disease